Clinical Features News Today

Sleep disorders encompass conditions that disrupt normal sleep patterns, posing a significant clinical challenge. They are prevalent and can profoundly impact physical, mental, social, and emotional well-being, leading to compromised health, safety, and quality of life. Studies demonstrate a notable decline in quality of life among individuals with insomnia. Insomnia, sleep-disordered breathing, hypersomnolence disorders, circadian […] - Newsx

Aaron Gerds, MD, MS, explores the FDA approval of momelotinib and its swift integration into National Comprehensive Cancer Network (NCCN) guidelines. He reviews different JAK inhibitors based on adverse effects and treatment goals, addressing potential treatment-related anemia in myelofibrosis.

From the impact of BMI on clinical features of bipolar disorder to FDA approval of the first integrated TMS system for MDD and OCD, here are highlights from the week in Psychiatric Times.

Aaron Gerds, MD, MS, explores myelofibrosis risk assessment, treatment goals, and therapeutic strategies, including JAK (Janus kinase inhibitors) inhibitors and transplant considerations.

Researchers identified patient- and tumor-level melanoma features in black individuals.

Do you have digestive problems like gas, diarrhea, or constipation? A proper diet can help you. Let's examine the low-FODMAP diet 2024 .

Aaron Gerds, MD, MS, compares myelofibrosis with other myeloproliferative neoplasms, explores its prevalence in the US, and reviews the diverse clinical presentations and the impact on patients’ quality of life.

A new GSK survey shows a large number of adults do not understand how shingles may be triggered1 More than half of adults surveyed incorrectly believe that you...

-- Alopecia areata is the second autoimmune indication being evaluated for bempikibart -- ...

GSK positive results from first-ever efficacy trial of Shingrix in China